Bayer has recently settled over 1,800 of the Yaz and Yasmin cases for approximately $402 million. In addition, according to the federally appointed mediator working on the cases, an additional 7,500 suits are expected to be settled by year’s end.
Hopefully this is a good indication of many future settlements down the road. If you are an attorney or plaintiff with Yaz/Yasmin settlements that are slow to pay out, RD Legal Funding can convert your unpaid legal receivables into immediate cash. Simply fill out the brief application to your right to schedule a consultation with one of our legal funding specialists.
Yaz and Yasmin, manufactured by Bayer, are birth control pills that contain the drug drospirenone. Birth control pills work by combining estrogen and progestin to alter women’s hormone levels. However, birth control pills made in the 1960’s using high levels of estrogen have been proven to cause elevated risks of stroke.
Yasmin and Yaz, approved by the FDA in 2001 and 2006, respectively, combined drospirenone (a new synthetic form of progestin) with smaller amounts of estrogen than other products on the market. In 2010, Yaz became the top selling birth control pill in the United States, generating $1.58 billion in sales. This can be attributed in part to multi-million dollar ad campaigns marketing the drug to women under the age of 35 as the birth control pill that also combatted premenstrual depression and acne.
A 2011 study by Danish scientists, which was published in the New England Journal of Medicine, found that women taking drospirenone containing birth control pills suffered strokes and heart attacks between 1.5 and 2 times more often than women not using hormonal contraception. In April of 2012, the FDA began requiring the labels of drospirenone containing birth control pills to display warnings of higher risk of blood clots. Other brand name drospirenone pills include Beyaz (a generic form of Yasmin distributed by Teva Pharmaceuticals) and Ocella (manufactured by Bayer).
In addition to an increased risk for blood clots and strokes, Yaz and Yasmin have been linked to an increased risk of venous thromboembolism, pulmonary embolism, deep vein thrombosis, and heart attacks. There are currently several thousand lawsuits against Bayer. The suits allege the manufacturer failed to provide adequate warning about these potentially fatal side effects.
A deep vein thrombosis is a blood clot that occurs in the deep veins of the legs or pelvis. A pulmonary embolism occurs when a blood clot breaks off, travels through the blood stream, and becomes lodged near the lung. October 2010 court records indicate that of the cases filed up to that time, approximately 40-41% involved a deep vein thrombosis or pulmonary embolism; 10% involved a heart attack or stroke from Yaz; and about 43% involved claims for gallbladder injury associated with Yaz.
RD Legal Funding is prepared to provide attorneys and the clients they represent with settlement financing on any slow-paying Yaz/Yasmin settlements. Since 1998, RD Legal Funding has been a leading provider of post-settlement cash flow solutions. If you would like to accelerate the payment of any settled fees you are owed, please fill out the brief application at the top of this page. If you would like to speak directly with a legal funding specialist, please call RD Legal toll-free at 1-800-565-5177.